Industry | Beverages—Wineries & Distilleries |
Sector | Consumer Staples |
Main Index | FRA_Other |
Company's (investor relations) website | Company Website |
Next earnings report | NaT |
Reporting currency | EUR |
Fiscal year period | 01/01-31/12 |
Reporting cycle | Semi-annual |
Last processed report | Q4-2021 |
Market Capitalization (in million) | € 77 |
Enterprise value | € 198 |
Shares outstanding (in million) | 3.8 |
ROE (Return on Equity) | 3.5% |
ROA (Return on Assets) | -1.0% |
EPS (Earnings Per Share) | € 0.88 |
PE (Price/Earnings) | 20.0 |
Beta | 0.37 |
Implicit value range | 0.006470597959031821|
Investment advice | Buy |
Trading advice   (based on moving averages) | Sell |
Latest StockAdvisor Algorithmic advice    see Return on Advice Graph | Sell |
Fundamental Strength (scale 0 - 100) | 17 |
Trading Strength (scale 0 - 100) | 27 |
1 year performance | 7.53% |
52 Weeks range | € 18.2 - 20.4 |
10 Day's Moving Average | Downtrend |
50 Day's Moving Average | Downtrend |
200 Day's Moving Average | Downtrend |
Revenue (last year in million) | € 281 |
5 year Revenue growth (5 year CAGR) | -0.27% |
Net income (last year in million) | € 3 |
5 year Net income growth (5 year CAGR) | 0% |
1 year target | € 30.28 |
3 year target | € 30.94 |
AdVini S.A. produces, markets, and distributes wines in France and internationally. The company was founded in 1870 and is headquartered in Clermont-l'Hérault, France. |
AdVini S.A. |
Davide Campari-Milano S.p.A. |
Diageo plc |
Lanson-BCC |
Laurent-Perrier S.A. |
Lombard et Medot SA |
Pernod Ricard SA |
Rémy Cointreau SA |
Description | 2020 | 2021 | 2022 | 2023 * | 2024 * | 2025 * |
Revenue | € 248 | € 281 | € 307 | € 328 | € 345 | € 358 |
Net income | € -4 | € 3 | € 4 | € 6 | € 8 | € 9 |
EPS | € -1.04 | € 0.88 | € 1.00 | € 1.51 | € 2.01 | € 2.37 |
PE | -20.54 | 21.70 | 21.53 | 17.42 | 15.09 | 13.32 |
Prices eoy | € 21.40 | € 19.10 | € 21.47 | € 26.33 | € 30.28 | € 31.58 |
Dividend | € 0.00 | € 0.50 | € 0.29 | € 0.38 | € 0.53 | € 0.47 |
Div-% | 0.0% | 2.6% | 1.4% | 1.4% | 1.7% | 1.5% |
Description | Q1-22 | Q2-22 | Q3-22 | Q4-22 | Q1-23 | Q2-23 | Q3-23 | Q4-23 |
Revenue | € 74 | € 76 | € 78 | € 79 | € 80 | € 81 | € 83 | € 84 |
Net income | € 0 | € 1 | € 2 | € 1 | € 1 | € 1 | € 2 | € 2 |
EPS | € 0.04 | € 0.20 | € 0.52 | € 0.24 | € 0.28 | € 0.34 | € 0.44 | € 0.45 |
PE | 28.38 | 29.81 | 22.24 | 21.53 | 19.49 | 18.27 | 18.38 | 17.42 |
Prices eoq | € 18.60 | € 21.40 | € 21.20 | € 21.47 | € 24.19 | € 25.16 | € 23.86 | € 26.33 |
Description | Look into |
Annual report 2016 | |
Annual report 2017 | |
Annual report 2018 | |
Annual report 2019 | |
Annual report 2020 |
NORM | ||||
Description | Actuals | Progressive | Neutral | Conservative |
Solvency | 24.2% | < 25% | 25-35% | > 35% |
ROE (return on equity) | -4.3% | > 12% | 10-12% | < 10% |
ROA (return on assets) | -1.0% | > 5% | 5% | < 5% |
Current ratio | 1.1 | < 1 | 1-1.5 | > 1.5 |
Turnover rate | 1.6 | < 1 | 1-1.5 | > 1.5 |
WACC | 5.01% | > 10% | 10% | < 10% |
Beta | 0.37 | > 1 | 1 | < 1 |